Alison L Van Dyke1, Troy J Kemp2, Amanda F Corbel3, Bin Zhu4, Yu-Tang Gao5, Bing-Sheng Wang6, Asif Rashid7, Ming-Chang Shen8, Allan Hildesheim3, Ann W Hsing9, Ligia A Pinto2, Jill Koshiol3. 1. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD. Electronic address: alison.vandyke@nih.gov. 2. HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD. 3. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD. 4. Biostatistics Branch, DCEG, NCI, Bethesda, MD. 5. Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. 6. Department of General Surgery, Zhongshan Hospital, School of Medicine, Fudan University, Shanghai, China. 7. Department of Pathology, MD Anderson Cancer Center, Houston, TX. 8. Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China; Department of Pathology, Cancer Hospital, Fudan University, Shanghai, China. 9. Center for Innovative Global Health, Stanford Cancer Institute, Stanford University, Stanford, CA.
Abstract
PURPOSE: We examined inflammation as a mediator of associations between bacterial infection markers and gallbladder cancer (GBC). METHODS: Bacterial response proteins (lipopolysaccharide [LPS], soluble cluster of differentiation 14 [sCD14], and LPS-binding protein [LBP]) were measured in 40 GBC cases and 126 gallstone controls with data on 63 serum inflammation markers. The relationships of LPS, LBP, and sCD14 with GBC were examined by logistic regression, which also was used to evaluate whether these associations are influenced by systemic inflammation as measured by a combinatorial inflammation score. RESULTS: The third versus the first tertiles of sCD14 and of LBP were associated with an increased GBC risk (odds ratio [95% confidence interval]: 5.41 [2.00-16.75] for sCD14, and 6.49 [2.24-23.79] for LBP). sCD14 and LBP were strongly associated with inflammation score (above vs. below the median), which itself was associated with a more than 21-fold increased risk of GBC for the third versus first tertiles. Associations between GBC and sCD14 and LBP were markedly attenuated when the inflammation score was included in the model. While LPS was not associated with GBC or inflammation, only 35% of cases and 22% of controls had detectable levels. CONCLUSIONS: These findings suggest that these LPS-pathway proteins are associated with GBC via inflammation-related pathways. Published by Elsevier Inc.
PURPOSE: We examined inflammation as a mediator of associations between bacterial infection markers and gallbladder cancer (GBC). METHODS: Bacterial response proteins (lipopolysaccharide [LPS], soluble cluster of differentiation 14 [sCD14], and LPS-binding protein [LBP]) were measured in 40 GBC cases and 126 gallstone controls with data on 63 serum inflammation markers. The relationships of LPS, LBP, and sCD14 with GBC were examined by logistic regression, which also was used to evaluate whether these associations are influenced by systemic inflammation as measured by a combinatorial inflammation score. RESULTS: The third versus the first tertiles of sCD14 and of LBP were associated with an increased GBC risk (odds ratio [95% confidence interval]: 5.41 [2.00-16.75] for sCD14, and 6.49 [2.24-23.79] for LBP). sCD14 and LBP were strongly associated with inflammation score (above vs. below the median), which itself was associated with a more than 21-fold increased risk of GBC for the third versus first tertiles. Associations between GBC and sCD14 and LBP were markedly attenuated when the inflammation score was included in the model. While LPS was not associated with GBC or inflammation, only 35% of cases and 22% of controls had detectable levels. CONCLUSIONS: These findings suggest that these LPS-pathway proteins are associated with GBC via inflammation-related pathways. Published by Elsevier Inc.
Authors: Ann W Hsing; Yu-Tang Gao; Katherine A McGlynn; Shelley Niwa; Mingdong Zhang; Tian-Quan Han; Bing-Sheng Wang; Jinbo Chen; Lori C Sakoda; Ming-Chang Shen; Bai-He Zhang; Jie Deng; Asif Rashid Journal: Int J Cancer Date: 2007-05-01 Impact factor: 7.396
Authors: Jill Koshiol; Felipe Castro; Troy J Kemp; Yu-Tang Gao; Juan Carlos Roa; Bingsheng Wang; Leticia Nogueira; Juan Carlos Araya; Ming-Chang Shen; Asif Rashid; Ann W Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M Pfeiffer; Ligia A Pinto Journal: Cytokine Date: 2016-05-09 Impact factor: 3.861
Authors: Y Hattori; S Tazuma; G Yamashita; H Ochi; Y Sunami; T Nishioka; H Hyogo; S Yasumiba; T Kajihara; K Nakai; K Tsuboi; Y Asamoto; M Sakomoto; G Kajiyama Journal: Dig Dis Sci Date: 2000-07 Impact factor: 3.199
Authors: Enju Liu; Lori C Sakoda; Yu-Tang Gao; Asif Rashid; Ming-Chang Shen; Bing-Sheng Wang; Jie Deng; Tian-Quan Han; Bai-He Zhang; Joseph F Fraumeni; Ann W Hsing Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Christopher E Savard; Thane A Blinman; Ho-Soon Choi; Sung-Koo Lee; Stephen J Pandol; Sum P Lee Journal: BMC Gastroenterol Date: 2002-10-11 Impact factor: 3.067
Authors: A W Hsing; Y-T Gao; T-Q Han; A Rashid; L C Sakoda; B-S Wang; M-C Shen; B-H Zhang; S Niwa; J Chen; J F Fraumeni Journal: Br J Cancer Date: 2007-11-13 Impact factor: 7.640
Authors: Zhiwei Liu; Troy J Kemp; Yu-Tang Gao; Amanda Corbel; Emma E McGee; Juan Carlos Roa; Bingsheng Wang; Juan Carlos Araya; Ming-Chang Shen; Asif Rashid; Ann W Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M Pfeiffer; Ligia A Pinto; Jill Koshiol Journal: Sci Rep Date: 2018-04-04 Impact factor: 4.379